Emodin alleviates gemcitabine resistance in pancreatic cancer by inhibiting MDR1/P‑glycoprotein and MRPs expression
- Type
- Retraction
- Notice date
- 7/15/2024 0:00
- Journal
- Oncology Letters
- Publisher
- Spandidos
- Notice DOI
- 10.3892/ol.2024.14568
- Original paper DOI
- 10.3892/ol.2020.12030
Reasons
- Author Unresponsive
- Concerns/Issues about Data
- Euphemisms for Plagiarism
- Investigation by Journal/Publisher
- Investigation by Third Party
- Plagiarism of Data